Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RITM
RITM logo

RITM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Rithm Capital Corp (RITM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
9.790
1 Day change
0.10%
52 Week Range
12.740
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Rithm Capital Corp (RITM) is not a strong buy for a beginner investor with a long-term focus at this time. The company's recent financial performance shows significant declines in revenue, net income, and EPS, which raises concerns about its growth prospects. While the stock offers an attractive dividend yield and analysts maintain a Buy rating, the lack of strong trading signals, hedge fund selling, and mixed technical indicators suggest that waiting for further clarity or improvement in financial performance would be prudent.

Technical Analysis

The MACD is positive and contracting, indicating a neutral to slightly bullish trend. RSI is in the neutral zone at 59.871, showing no clear overbought or oversold conditions. Moving averages are converging, and the stock is trading near its pivot level of 10.057, with resistance at 10.237 and support at 9.878.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
4

Positive Catalysts

  • Analysts maintain a Buy rating with price targets ranging from $12.50 to $14.50, implying potential upside.

  • Attractive dividend yield of $1 per share annually.

  • Stock trend analysis indicates a 70% chance of a 6.2% gain in the next week and 8.77% in the next month.

Neutral/Negative Catalysts

  • Hedge funds are selling, with a 284.34% increase in selling over the last quarter.

  • Financial performance in Q4 2025 showed significant declines: revenue down 24.86% YoY, net income down 79.82% YoY, and EPS down 82.00% YoY.

  • Pre-market price is down 0.10%, indicating weak sentiment.

  • No recent congress trading data or strong proprietary trading signals.

Financial Performance

In Q4 2025, revenue dropped to $1.36 billion (-24.86% YoY), net income fell to $53.12 million (-79.82% YoY), and EPS declined to $0.09 (-82.00% YoY). Gross margin also decreased to 68.87 (-8.34% YoY), reflecting a challenging operating environment.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain a Buy rating with price targets recently adjusted downward. UBS lowered its target to $14.50 from $15, Piper Sandler to $14 from $15, and Lucid Capital initiated coverage with a $12.50 target. Analysts highlight the company's transparency and dividend yield but note challenges in the mortgage sector due to market volatility.

Wall Street analysts forecast RITM stock price to rise
6 Analyst Rating
Wall Street analysts forecast RITM stock price to rise
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 9.780
sliders
Low
14
Averages
14.92
High
16
Current: 9.780
sliders
Low
14
Averages
14.92
High
16
Wedbush
Michael Piccolo
Outperform
to
Outperform
downgrade
$14
AI Analysis
2026-05-01
New
Reason
Wedbush
Michael Piccolo
Price Target
$14
AI Analysis
2026-05-01
New
downgrade
Outperform
to
Outperform
Reason
Wedbush analyst Michael Piccolo lowered the firm's price target on Rithm Capital to $12.50 from $14 and keeps an Outperform rating on the shares to reflect an updated dividend yield-based valuation methodology. The firm believes the 25c per share quarterly dividend, covered more than two times by Q1 EAD of 51c per share, represents one of the most durable and well-covered income streams in the hybrid mortgage REIT universe, and Wedbush views the shares as an attractive entry point for income-oriented investors.
Keefe Bruyette
Outperform
to
Outperform
downgrade
$14 -> $13
2026-05-01
New
Reason
Keefe Bruyette
Price Target
$14 -> $13
2026-05-01
New
downgrade
Outperform
to
Outperform
Reason
Keefe Bruyette lowered the firm's price target on Rithm Capital to $13 from $14 and keeps an Outperform rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for RITM
Unlock Now

People Also Watch